Ibrance 75 MG capsule 21S
Ended Awarded
- Contract number
- SPE2DB25FQZNB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,124
Award facts
- Contract value 100% obligated
- $8,123.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Ibrance 75 mg capsules (21-count packages) valued at $8,123.96 with an ultimate completion date of September 26, 2025. This contract represents a firm fixed-price delivery order under a non-set-aside competitive procurement, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Ibrance is a prescription pharmaceutical used in oncology treatment, reflecting the critical medical supply needs of federal healthcare systems, particularly those serving military personnel and veterans.
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The contract demonstrates AmerisourceBergen's established capability as a major federal pharmaceutical distributor, supplying medications across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DB25FQZNB?
SPE2DB25FQZNB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FQZNB worth?
The government has obligated $8,124 on SPE2DB25FQZNB.
Is contract SPE2DB25FQZNB an order under another contract?
Yes. SPE2DB25FQZNB is a delivery order under SPE2DB25D3021, an indefinite delivery contract.
Was contract SPE2DB25FQZNB competed?
The extent of competition for SPE2DB25FQZNB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award